Virtual Global Summit
How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit
Overview
Event Highlights
- Head and neck cancer care is becoming increasingly personalized, with molecular biology, HPV status, circulating tumor DNA, biomarkers, disease risk, and treatment response guiding clinical decisions.
- De-escalation and adaptive treatment strategies are gaining importance, particularly in HPV-positive oropharyngeal cancer and precision radiotherapy, with the goal of reducing toxicity without compromising outcomes.
- Multidisciplinary collaboration remains essential, bringing together surgery, radiotherapy, systemic therapy, pathology, imaging, and case-based decision-making to individualize care.
- Emerging systemic therapies are expanding treatment possibilities, including immunotherapy, antibody–drug conjugates, bispecific antibodies, fusion proteins, and tyrosine kinase inhibitors.
- Progress must include quality of life and equitable access to care, ensuring that survival improvements are accompanied by better functional outcomes, earlier diagnosis, affordability, and access across diverse healthcare settings.
Event Series
Date / Time
Apr 30, 2026 · 10:00 AM – 10:00 PM
The OncoDaily How I Treat series returned with a dedicated summit on head and neck cancers, held live on April 30, 2026, to close Head and Neck Cancers Awareness Month.
Head and neck cancers account for more than 890,000 new diagnoses and over 450,000 deaths worldwide each year. Although early-stage disease is often curable, many patients continue to be diagnosed at later stages, when treatment becomes more complex and outcomes are poorer.
The summit brought together leading experts from across the world to examine how immunotherapy, precision oncology, and advances in surgical and radiation techniques are transforming the management of head and neck cancers. Through practical and experience-based discussions, the meeting helped bridge the gap between emerging scientific evidence and real-world clinical practice.
Scientific Program
The scientific program covered the full clinical pathway, from risk-stratified management of suspected and early-stage disease to evidence-based treatment approaches for locally advanced, recurrent, and metastatic cancers.
Sessions addressed systemic therapy selection, multidisciplinary coordination, organ-preservation strategies, transoral and minimally invasive surgical techniques, and advances in radiation therapy. Speakers shared real-world perspectives on improving oncologic outcomes while preserving function, quality of life, and treatment accessibility across diverse healthcare systems.
The summit successfully delivered a dedicated day of discussion focused on head and neck cancer science, clinical decision-making, radiation techniques, surgical innovation, and global perspectives.
By bringing together expert voices from across continents, the event strengthened multidisciplinary knowledge exchange, highlighted practical treatment strategies, and advanced a more patient-centered and globally informed approach to head and neck cancer care in 2026.
Scientific Program
The scientific program covered the full clinical pathway, from risk-stratified management of suspected and early-stage disease to evidence-based treatment approaches for locally advanced, recurrent, and metastatic cancers.
Sessions addressed systemic therapy selection, multidisciplinary coordination, organ-preservation strategies, transoral and minimally invasive surgical techniques, and advances in radiation therapy. Speakers shared real-world perspectives on improving oncologic outcomes while preserving function, quality of life, and treatment accessibility across diverse healthcare systems.
The summit successfully delivered a dedicated day of discussion focused on head and neck cancer science, clinical decision-making, radiation techniques, surgical innovation, and global perspectives.
By bringing together expert voices from across continents, the event strengthened multidisciplinary knowledge exchange, highlighted practical treatment strategies, and advanced a more patient-centered and globally informed approach to head and neck cancer care in 2026.
